Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They beat by .03. Bios have been taking a hit now for a week or so. Time to set alerts and watch for bottoms.
$LXRX. Looking good. See this in a week or 2.
JMHO.
Nice. Nice volume too. Looks like a bunch of bios are making the turn the last couple of days. PLX, SCYX, EVAX asa well.
I bought a nice chunck in the mid .08's. I'll take more. They could still get an extension, or pull the RS action. And they need to watch their financing and avoid defaults.
Let's just say this puppy is stacked full of the "IF" factor. "What if" this and that and everything else.
My vote is they get an extension. Then this regains compliance.
Dreamin!! anything can happen.
NEWS: Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
October 31, 2023 11:15 ET
| Source: Evaxion Biotech
https://www.globenewswire.com/news-release/2023/10/31/2770437/0/en/Evaxion-Announces-Encouraging-Initial-Phase-2-Clinical-Data-on-Its-Personalized-Cancer-Vaccine-EVX-01.html
My gamble is that LMDX is granted an additional 180 days to regain compliance.
I think it's a gamble for sure, but it could happen. News after lunch or close today if it's going to happen. Delist on Thursday if not.
$SCYX 1.81 EVAX hod 1.10
SCYX daily, I like it.
EVAX daily, see if it holds the $
Watching ENSC, more convertibles, and dipped under the $
Watching MYNZ and BNGO.
LMDX long .086. Don't follow me. lol
High $1.10.
$LMDX Cutting it to the wire but this could be granted another 180 days. It used to happen quite often, not sure about nowa days.
Thinking their convertibles will hold this back for a bit. Getting ready to give away even more...
https://ih.advfn.com/stock-market/NASDAQ/ensysce-biosciences-ENSC/stock-news/92404486/form-pre-14a-other-preliminary-proxy-statements
Low of .81 yesterday. Dodged the drop on this but still keeping it on my list.
Looks like quite the story for LMDX. "Do or die" situation imo. Not an overnighter imo.
Added to my "story stock" list.
$RNAZ That would be something. On the other hand, their withdrawel of the offering, which btw, had no price announced with it, reallly does nothing for them imo. They just finished an offering the end of September.
Suspicious. imo.
They do still have pending trial news, that, imo, is their next catalyst.
Oct-30-23 04:33PM
TransCode Therapeutics Withdraws Public Offering
(GlobeNewswire)
+10.36%
Oct-27-23 08:16AM
Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today?
(InvestorPlace)
-21.61%
08:00AM
Nasdaq Panel Grants TransCode Therapeutics Extension for Continued Listing on The Nasdaq Stock Market Subject to Conditions
(GlobeNewswire)
Oct-26-23 04:19PM
TransCode Therapeutics Announces Public Offering of Common Stock
(GlobeNewswire)
+12.13%
08:00AM
TransCode Therapeutics Announces Prolonged Survival in Murine Models with Glioblastoma Treated with Its Lead Candidate, TTX-MC138
(GlobeNewswire)
08:00AM
Many trading strategies involve options writing (selling) where the primary risks are market movement and volatility. But there’s another risk if you happen to be writing options on dividend-paying equities like SPY ETFs—early assignment.
Sponsored By : Cboe Global Markets, Inc.
Oct-24-23 08:00AM
TransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Study with Lead Therapeutic Candidate, TTX-MC138
(GlobeNewswire)
+40.39%
Oct-16-23 08:00AM
TransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGA
(GlobeNewswire)
+5.84%
Sep-28-23 04:02PM
TransCode Therapeutics Announces Closing of $8.5 Million Public Offering
(GlobeNewswire)
Sep-25-23 08:01PM
TransCode Therapeutics Announces Pricing of $8 Million Public Offering
(GlobeNewswire)
+284.04%
1.20 new low. Divergence starting to tighten up a bit more. Needs the volume and find a solid bottom. Getting closer imo.
Maybe this time the push actually happens!!
Small bite, .705. Only looking at the daily of how the candles dip before a short term bounce.
H&S, looks like this'll be under the $. Keeping it on radar though.
Getting ready for a new offering while this is in the .20's/.30's? And then the underwriters can get a %15 discount on top of that?
Any guess where the offering price will be? My wild guss is .33 - .37 for what? $8 - $15M? That's a LOT of continued dilution. Up to 42M shares ought to cover it. Maybey they can get to 150M OS by the time they delist or do another RS around New Years.
I still think there's some news pending that could make this risk worthy by Christmas.
I like roulette.
Pump didn't work for this offering, that's for sure.
0.432401 nice. lmao. LII's look very very thin into the .50's.
This has a pretty good spin on it. I think their last $8M offering was .51. Not hard to see why it can't get past it.
But if the news brings hoe the bacon...
My simple mind tells me this is in the barrell with a zillion other bio's just like it. If they can launch a phase 1 and somehow manage to stay off the OTC till then, it may have a chance. I haven't dug to much into this one. Just playing the hype, and the shorts seem to be playing it too. Just my guess.
Get over the $ and regain compliance. That would be a nice move.
Yes,this is in concert to dilute imo. The news "blast" period, for 1 reason only (imo of course) to fill the pockets of their financing friends...
HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target
12:03 pm ET October 24, 2023 (Benzinga) Print
HC Wainwright & Co. analyst Emily Bodnar reiterates TransCode Therapeutics (NASDAQ:RNAZ) with a Buy and maintains $3 price target.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Although, their 1 patient news earlier this week should be followed soon with the rest of the patients soon. And then possibly a pipeline boost from the FDA with some kind of fast track or something else, if they don't have it already.
Not saying this doesn't have $ potential, these micro floaters can scream right through some tough resistance sometimes.
Again, this is only my opinion. I'll take the .15 or so flips all day long.
BNGO watching for bottom. Major dillution machine pos imo. Thinking early next week for a play.
Radar.
Still no bottom yet.
I was just looking at this. Since it looks to be getting the crap kicked out of it. $1.30's, $80M offering (WOW!) and to see what else is happening. Benn a while since I was in this one.
Looks like it's starting to set up. Ned to see bottom confirmation.
News: TransCode Therapeutics Announces Prolonged Survival in Murine Models with Glioblastoma Treated with Its Lead Candidate, TTX-MC138
TransCode Therapeutics, Inc.
https://finance.yahoo.com/news/transcode-therapeutics-announces-prolonged-survival-120000724.html
These micro floats can still pop like crazy. .40's now.
Not even pegging the oversolds yet.
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.
https://www.accesswire.com/viewarticle.aspx?id=796208
She's got a nice squeeze look to her... RNAZ
And of course the dilution is evident...
October 24, 2023
12:12 pm ET
Transcode Therapeutics Price Target Maintained With a $3.00/Share by HC Wainwright & Co.
Dow Jones
12:03 pm ET
HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target
Benzinga
Saw $RNAZ mentioned this morning with news. Micro float, tightening bollinger...
This puppy could do many things, if the MM's let it rip and the company gets off the dillution just for a coupel days.
RNAZ daily
INM, another micro floater. Crazy.
1.80 high, so far. Like to see this fill the gap in the 1.40's. Liking the swings though for sure.
Some decent swing action this morning.
High 1.53. $ENSC
Wasn't even on my list. Nice Monk!
This needs the volume to really do anything. Getting some pincher indicators, and if any volume does start coming in the float is smal enough to let it rip.
Roll of the dice right now imo.
$ENSC low volume but appears to be setting up nicely.
ENSC daily
A few technical plays. We'll see how they pan out.
BooDog
Re: BooDog post# 609932
Friday, October 06, 2023 12:04:59 PM
Post#
610083
of 610092
Took QBET .92 PLX 1.65.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172974045
And LXRX 1.06. Still not sure if LXRX formed a solid bottom but thought I'd risk a few. Same with the others really.
VCNX Crazy volume seemingly on thin air. Offering @ the $ and it goes nuts on volume?
interesting.
.ahhh, i see, they did a RS and the float is like WAY low.
Flippers delight.